Supplement to Cutaneous Toxicities of Immune Checkpoint Inhibitors in Patients with Altered Immunity
Published: 11 January 2021| Version 2 | DOI: 10.17632/66525prn5p.2
This supplemental material to our manuscript "Cutaneous Toxicities of Immune Checkpoint Inhibitors in Patients with Altered Immunity" describes in further detail the process by which data was obtained and patients screened for inclusion, in addition to how reactions were graded by severity. Patients with solid organ transplants and HIV were included in our study, which catalogs the rate and characteristics of cutaneous adverse reactions seen in these patients.
Harvard Medical School, Massachusetts General Hospital
Dermatology, Transplantation, Drug Adverse Reactions, HIV/AIDS, Immune Checkpoint Blockade